
    
      Patients with severe cutaneous adverse reactions (Steven-Johnson Syndrome, toxic epidermal
      necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized
      exanthematous pustulosis, and generalized bullous fixed drug eruption) among six tertiary
      medical institutes in Thailand will be recruited to study clinical characteristics,
      etiologies, therapeutic outcomes, quality of life, and the values of using laboratory
      techniques for the confirmation of the causative drugs
    
  